The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase III study comparing stereotactic body radiotherapy (SBRT) versus conventional palliative radiotherapy (CRT) for participants with painful non-spine bone metastases (NCT06391242).
 
Arjun Sahgal
Leadership - Elekta; ISRS
Honoraria - AstraZeneca; BrainLAB; CarboFix Orthopedics; Cerapedics; Elekta; Seagen; Varian Medical Systems
Consulting or Advisory Role - BrainLAB; Elekta; Varian Medical Systems
Research Funding - Elekta (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Clustering software for Gamma Knife treatment planning (Inst)
Travel, Accommodations, Expenses - BrainLAB; Elekta; Seagen; Varian Medical Systems
Other Relationship - AO Spine; BrainLAB; Elekta; Elekta; Elekta; Elekta MRL Consortium; International Stereotactic Radiosurgery Society; Varian Medical Systems
 
Tim Nguyen
No Relationships to Disclose
 
Laura Masucci
Honoraria - AstraZeneca Canada; Cerapedics, Inc.
 
Kristopher Dennis
No Relationships to Disclose
 
Emma Dunne
No Relationships to Disclose
 
Anand Swaminath
Employment - Roche (I)
Honoraria - AstraZeneca Canada
 
Isabelle Thibault
Honoraria - AstraZeneca Canada inc.
Consulting or Advisory Role - AstraZeneca Canada
 
Chiaojung Jillian Tsai
Employment - Princess Margaret Cancer Centre
Honoraria - Varian Medical Systems; Varian Medical Systems; Varian Medical Systems
Consulting or Advisory Role - Varian Medical Systems
 
Pejman Maralani
Patents, Royalties, Other Intellectual Property - US Provisional PatentNo 63/696,215
 
Michael Brundage
Research Funding - Pfizer (Inst)
 
Marc Kerba
Honoraria - AstraZeneca
 
Joel Lefebvre
No Relationships to Disclose
 
Wei Tu
No Relationships to Disclose
 
Wendy Parulekar
No Relationships to Disclose